Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient

Immunogenetics

Volumn 47, Issue 5, 1998, Pages 398-403

  Kobayashi, Hiroya ^a   Kokubo, Taku ^a   Takahashi, Michinari ^a   Sato, Keisuke ^a   Miyokawa, Naoyuki ^a   Kimura, Shoji ^a   Kinouchi, Reiko ^a   Katagiri, Makoto ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

HLA; Peptide; T cell response; Tyrosinase; VKH disease

Indexed keywords

AUTOANTIGEN; HLA DR ANTIGEN; MONOPHENOL MONOOXYGENASE; SYNTHETIC PEPTIDE;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VOGT KOYANAGI SYNDROME;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; AUTOANTIGENS; CELL DIVISION; CELLS, CULTURED; DNA; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 0031914902     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050375     Document Type: Article

References (35)

1. Aparitio, R. J. M., Wakisaka, A., Takada, A., Matsuura, N., and Aizawa, M. HLA-DQ systems and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does Caucasians? Immunogenetics 28: 240-246, 1988
2. Beniz, J., Forster, D. J., Lean, J. S., Smith, R. E., Rao, N. A. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 11: 275-280
3. Birchard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. (1993) The tyrosinase gene codes for an antigen recognised by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178: 489-495, 1993
4. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., and Wiley, D. C. Three-dimensional structure of the human class-II histocompatibility antigen HLA-DR1. Nature 364: 33-39, 1993
5. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A. A., Lane, W. S., and Strominger, J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR allele. J Exp Med 178: 22-47, 1993
6. Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J.-P., Renauld, J.-C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180, 35-42, 1994
7. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D., and Singluff, C. L. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264: 716-719, 1994
8. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179: 921-930, 1994
9. Halder, T., Pawelec, G., Kirkin, A. F., Zeuthern, J., Meyer, H. E., and Kalbacher, H. Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3. Cancer Res 57: 3238-3244, 1997
10. Jim'enze, M., Kameyama, K., Maloy, W. L., Tomita, Y., and Hearing, V. J. Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone. Proc Natl Acad Sci USA 85: 3830-3834, 1988
11. + T cells specific to streptococcal antigen present in low but not in high responders. J Immunol 146: 2560-2567, 1991
12. Kang, X., Kawakami, Y., El-Gamil, M., Wang, R., Sakaguchi, K., Yannelli, J. R., Appella, E., Rosenberg, S. A., and Robbins, P. F. Identification of a tyrosinase epitope recognized by HLA-A-24-restricted, tumor-infiltrating lymphocytes. J Immunol 155: 1343-1348, 1995
13. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. E. Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad USA 91: 3515-3519, 1994a
14. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91: 6458-6482, 1994b
15. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180: 347-352, 1994c
16. Kawakami, Y. Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbings, P. F., Sette, A., Appella, E., and Rosenberg, S. A. Recognition multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 154: 3961-3968, 1995
17. Kinouchi, R., Kobayashi, H., Sato, K., Kimura, S., and Katagiri, M. Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB4*0101) molecules. Immunogenetics 40: 376-378, 1994
18. Kobayashi, H., Kokubo, T., Abe, Y. Sato, K., Kimura, S., Miyokawa, N., and Katagiri, M. Analysis of anchor residues in a naturally processed HLA-DR53 ligand. Immunogenetics 44: 366-371, 1996
19. Matsushita, S., Takahashi, K., Motoki, M., Komoriya, K., Ikagawa, S., and Nishimura, Y. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazol-induced insulin autoimmune syndrome. J Exp Med 180: 873-883, 1994
20. Moriuchi, J., Katagiri, M., Wakisaka, A., Ikeda, H., Maruyama, N., Tagawa, Y., Aizawa, M., and Itakura, K. Association of B-cell alloantigenic determinant Hon 7, with Harada's disease. Immunogenetics 9: 487-489, 1979
21. Nepom, G. T. and Erlich, H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 9: 493-525, 1991
22. Niizeki, H., Inoko, H., Narimatsu, H., Takata, H., Sonoda, A., Tadakuma, T., Ando, A., Tsuji, K., Hashimoto, T., and Nishikawa, T. HLA class II antigens are associated with Japanese pemphigus patients. Hum Immunol 31: 246-250, 1991
23. Ohno, S. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's disease. Trans Ophthalmol Soc UK 101: 335-341, 1981
24. Rammensee, H.-G., Friede, T., Stevanović S. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228, 1995
25. Rothbard, B. J. and Gefter, M. L. Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol 9: 527-565, 1991
26. Salgaller, M. L., Afshar, A., Marincola, F. M., Rivoltini, L., Kawakami, Y., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res 55: 4972-4979, 1995
27. Shindo, Y. Ohno, S., Nakamura, S., Onoe, K., and Inoko, H. A significant association of HLA-DPB1*0501 with Vogt-Koyanagi-Harada's disease results from a linkage disequilibrium with the primarily associated allele, DRB1*0405. Tissue Antigens 47: 344-345, 1996
28. Snyder, D. A., Tessler, H. H., Yokoyama, M. M. Immunologic studies on Vogt-Koyanagi-Harada syndrome and pars planitis. In A. M. Silverstein and G. R. O'Connor (eds.): Immunology and Immunopathology of the Eye, pp. 68-75, Masson, New York, 1978
29. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., and Wiley, D. C. Crystal structure of the human MHC class-II protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215-221, 1994
30. Sugiura, S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 22: 9-35, 1978
31. Todd, J. A., Archa-Orbea, H., Bell, J. I., Chao, N., Fronek, Z., Jacob, C. O., McDermott, M., Sinha, A. A., Timmerman, L., Steinman, L., and McDevitt, H. O. A molecular basis for MHC class II-associated autoimmunity. Science 240: 1003-1009, 1988
32. Tsuchiya, K., Kondo, M., Kimura, A., Nishimura, Y. and Sasazuki, T. The HLA-DRB1 and/or the DQB1 locus controls susceptibility and DRBI locus controls resistance to rheumatoid arthritis in the Japanese. In HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference (Vol 2): pp. 509-512, 1991
33. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647, 1991
34. Wolfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Buschenfelde, K.-H., and Boon, T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas autologous cytolytic T lymphocytes. Eur J Immunol 24: 759-764, 1994
35. Zohu, B.-K., Boissy, R. E., Pifko-Hirst, S., Moran, D. J., and Orlow, S. J. Lysosome-associated membrane protein-1 (LAMP-1) is the melanocyte vesicular glycoprotein band II. J Invest Dermatol 100: 110-114, 1993